We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
51
Intuitive Surgical
ISRG
$135B
$28M 0.41%
82,000
-126,000
-61% -$38.1M
IMCR icon
52
Immunocore
IMCR
$1.65B
$25.7M 0.37%
428,000
+50,000
+13% +$2.85M
BMY icon
53
Bristol-Myers Squibb
BMY
$134B
$25.6M 0.37%
+400,000
New +$26.8M
BABA icon
54
Alibaba
BABA
$305B
$25M 0.36%
300,000
+150,000
+100% +$13.1M
TMO icon
55
Thermo Fisher Scientific
TMO
$213B
$23.5M 0.34%
45,000
+3,000
+7% +$1.62M
LLAP
56
DELISTED
Terran Orbital Corporation
LLAP
$23M 0.33%
+15,325,000
New +$24.3M
KURA icon
57
Kura Oncology
KURA
$816M
$22.5M 0.33%
2,124,000
+888,000
+72% +$10.5M
BCYC
58
Bicycle Therapeutics
BCYC
$270M
$22.4M 0.32%
876,000
+140,000
+19% +$3.25M
XNCR icon
59
Xencor
XNCR
$1.44B
$22.3M 0.32%
892,000
+56,000
+7% +$1.52M
RIGL icon
60
Rigel Pharmaceuticals
RIGL
$693M
$22.1M 0.32%
1,710,000
+7,600
+0.4% +$103K
NOMD icon
61
Nomad Foods
NOMD
$1.68B
$21.9M 0.32%
1,250,000
+965,000
+339% +$17.6M
PM icon
62
Philip Morris
PM
$292B
$21.9M 0.32%
+224,000
New +$21.4M
TOST icon
63
Toast
TOST
$19B
$21.8M 0.31%
964,000
-856,370
-47% -$17.1M
ERAS icon
64
Erasca
ERAS
$6.19B
$21.7M 0.31%
7,856,000
+506,000
+7% +$1.44M
UBER icon
65
Uber
UBER
$146B
$21.6M 0.31%
500,000
-592,000
-54% -$22M
MCD icon
66
McDonald's
MCD
$188B
$20.9M 0.3%
70,000
+25,000
+56% +$7.26M
YUM icon
67
Yum! Brands
YUM
$40.6B
$20.5M 0.3%
148,000
-33,000
-18% -$4.47M
LYV icon
68
Live Nation Entertainment
LYV
$42.3B
$20M 0.29%
+219,000
New +$17.1M
SPPI
69
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$19.2M 0.28%
20,000,000
+3,300,000
+20% +$3.26M
DECK icon
70
Deckers Outdoor
DECK
$13.6B
$19M 0.27%
216,000
-33,756
-14% -$2.71M
LOW icon
71
Lowe's Companies
LOW
$119B
$18.7M 0.27%
83,000
-28,729
-26% -$5.98M
WDAY icon
72
Workday
WDAY
$40.8B
$18.5M 0.27%
82,000
-10,000
-11% -$2M
DDOG icon
73
Datadog
DDOG
$97.4B
$18.5M 0.27%
188,000
-72,000
-28% -$6.02M
BBAI icon
74
BigBear.ai
BBAI
$1.37B
$17.6M 0.26%
+7,500,000
New +$19M
AUTL
75
Autolus Therapeutics
AUTL
$484M
$17.3M 0.25%
7,264,000
-2,408,000
-25% -$5.71M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.